COMMONWEALTH EQUITY SERVICES, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$55,000
-5.2%
10,165
-21.7%
0.00%
Q2 2022$58,000
-39.6%
12,990
-0.8%
0.00%
Q1 2022$96,000
+9.1%
13,090
-4.4%
0.00%
Q4 2021$88,000
+18.9%
13,690
+7.5%
0.00%
Q3 2021$74,000
-52.6%
12,740
+25.7%
0.00%
Q4 2020$156,000
-18.8%
10,134
+0.8%
0.00%
-100.0%
Q4 2019$192,000
+54.8%
10,052
-22.3%
0.00%0.0%
Q3 2019$124,00012,9370.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$13,170,0009.51%
Palo Alto Investors LP 5,383,052$31,329,0001.89%
Birchview Capital, LP 246,000$1,432,0000.97%
Rubric Capital Management LP 3,375,758$19,647,0000.55%
Lombard Odier Asset Management (Switzerland) SA 1,517,804$8,834,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 1,401,861$8,159,0000.30%
AlphaCentric Advisors LLC 136,000$792,0000.20%
Bridgefront Capital, LLC 20,946$122,0000.13%
Hennion & Walsh Asset Management, Inc. 407,474$2,371,0000.12%
Virtus ETF Advisers LLC 44,364$258,0000.11%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders